NASDAQ:BRKR - Bruker Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $37.90 -0.27 (-0.71 %) (As of 04/23/2019 06:11 AM ET)Previous Close$38.17Today's Range$37.76 - $38.6552-Week Range$26.10 - $40.25Volume615,600 shsAverage Volume689,968 shsMarket Capitalization$5.94 billionP/E Ratio27.07Dividend Yield0.42%Beta1.47 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts. Receive BRKR News and Ratings via Email Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNASDAQ:BRKR Previous Symbol CUSIP11679410 CIK1109354 Webwww.bruker.com Phone978-663-3660Debt Debt-to-Equity Ratio0.36 Current Ratio2.18 Quick Ratio1.33Price-To-Earnings Trailing P/E Ratio27.07 Forward P/E Ratio24.14 P/E Growth2.1 Sales & Book Value Annual Sales$1.90 billion Price / Sales3.13 Cash Flow$1.8091 per share Price / Cash Flow20.95 Book Value$5.78 per share Price / Book6.56Profitability EPS (Most Recent Fiscal Year)$1.40 Net Income$179.70 million Net Margins9.48% Return on Equity26.36% Return on Assets11.39%Miscellaneous Employees6,870 Outstanding Shares156,742,000Market Cap$5.94 billion Next Earnings Date5/2/2019 (Estimated) OptionableOptionable Bruker (NASDAQ:BRKR) Frequently Asked Questions What is Bruker's stock symbol? Bruker trades on the NASDAQ under the ticker symbol "BRKR." How often does Bruker pay dividends? What is the dividend yield for Bruker? Bruker declared a quarterly dividend on Friday, February 15th. Stockholders of record on Tuesday, March 5th will be paid a dividend of $0.04 per share on Friday, March 22nd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date of this dividend is Monday, March 4th. View Bruker's Dividend History. How will Bruker's stock buyback program work? Bruker announced that its Board of Directors has initiated a stock repurchase plan on Sunday, June 4th 2017, which authorizes the company to repurchase $225,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its shares are undervalued. How were Bruker's earnings last quarter? Bruker Co. (NASDAQ:BRKR) issued its earnings results on Monday, February, 11th. The medical research company reported $0.54 EPS for the quarter, meeting the Zacks' consensus estimate of $0.54. The medical research company earned $553.60 million during the quarter, compared to analyst estimates of $544.53 million. Bruker had a return on equity of 26.36% and a net margin of 9.48%. View Bruker's Earnings History. When is Bruker's next earnings date? Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Bruker. What guidance has Bruker issued on next quarter's earnings? Bruker updated its FY 2019 earnings guidance on Monday, February, 11th. The company provided earnings per share (EPS) guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion. What price target have analysts set for BRKR? 6 brokers have issued 1 year price targets for Bruker's shares. Their predictions range from $30.00 to $50.00. On average, they anticipate Bruker's share price to reach $38.1667 in the next year. This suggests a possible upside of 0.7% from the stock's current price. View Analyst Price Targets for Bruker. What is the consensus analysts' recommendation for Bruker? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker. Has Bruker been receiving favorable news coverage? Media headlines about BRKR stock have been trending negative on Tuesday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bruker earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near future. Who are some of Bruker's key competitors? Some companies that are related to Bruker include Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM) and BioNano Genomics (BNGO). What other stocks do shareholders of Bruker own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include General Electric (GE), Mattel (MAT), Ultra Clean (UCTT), Twitter (TWTR), Clear Channel Outdoor (CCO), US Foods (USFD), American National BankShares (AMNB), General Motors (GM), New York Times (NYT) and Buffalo Wild Wings (BWLD). Who are Bruker's key executives? Bruker's management team includes the folowing people: Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)Stacey Desrochers, Treasurer & Director of Investor Relations Who are Bruker's major shareholders? Bruker's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BTIM Corp. (0.39%), CWM LLC (0.18%), Scout Investments Inc. (0.11%), Meeder Asset Management Inc. (0.02%), Tibra Equities Europe Ltd (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker. Which institutional investors are selling Bruker stock? BRKR stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc. and First Hawaiian Bank. View Insider Buying and Selling for Bruker. Which institutional investors are buying Bruker stock? BRKR stock was bought by a variety of institutional investors in the last quarter, including Tibra Equities Europe Ltd, CWM LLC, Calamos Advisors LLC, Meeder Asset Management Inc., Sciencast Management LP, Virtu Financial LLC, BTIM Corp. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Bruker. How do I buy shares of Bruker? Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bruker's stock price today? One share of BRKR stock can currently be purchased for approximately $37.90. How big of a company is Bruker? Bruker has a market capitalization of $5.94 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe. What is Bruker's official website? The official website for Bruker is http://www.bruker.com. How can I contact Bruker? Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected] MarketBeat Community Rating for Bruker (NASDAQ BRKR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 551 (Vote Outperform)Underperform Votes: 601 (Vote Underperform)Total Votes: 1,152MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/23/2019 by MarketBeat.com StaffFeatured Article: What is an investor looking for in an SEC filing?